scout
Opinion|Videos|March 8, 2024

LEAP Study: Lenvatinib Plus Pembrolizumab in Patients With RCC and Brain Metastasis

Chandler H. Park, MD, discusses the LEAP study investigating lenvatinib plus pembrolizumab in patients with renal cell carcinoma with brain metastasis.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME